Urgent.News

What's breaking now, across thousands of outlets.

AI

Palantir Stock: Buy, Sell, or Hold After a Research Firm's AI Warning?

A major AI forecast is putting Palantir's operating model under the microscope. The numbers investors watch next could reveal whether its unusual strategy is a weakness or a lasting advantage.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Read the original at fool.com →

More in AI

Claude did not invent scorpion antivenom

An investment research firm wanted to prove AI could revolutionize drug development. So they teamed up with Anthropic to see whether an unreleased version of Claude could make scorpion antivenom.

More from Thursday 22 October →